BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36810451)

  • 1. Efficient and accurate KRAS genotyping using digital PCR combined with melting curve analysis for ctDNA from pancreatic cancer patients.
    Tanaka J; Nakagawa T; Harada K; Morizane C; Tanaka H; Shiba S; Ohba A; Hijioka S; Takai E; Yachida S; Kamura Y; Ishida T; Yokoi T; Uematsu C
    Sci Rep; 2023 Feb; 13(1):3039. PubMed ID: 36810451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-Plex Digital Polymerase Chain Reaction with Four-Color Melting Curve Analysis for Simultaneous
    Nakagawa T; Tanaka J; Harada K; Shiratori A; Shimazaki Y; Yokoi T; Uematsu C; Kohara Y
    Anal Chem; 2020 Sep; 92(17):11705-11713. PubMed ID: 32786457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital PCR Improves Mutation Analysis in Pancreas Fine Needle Aspiration Biopsy Specimens.
    Sho S; Court CM; Kim S; Braxton DR; Hou S; Muthusamy VR; Watson RR; Sedarat A; Tseng HR; Tomlinson JS
    PLoS One; 2017; 12(1):e0170897. PubMed ID: 28125707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients.
    Taly V; Pekin D; Benhaim L; Kotsopoulos SK; Le Corre D; Li X; Atochin I; Link DR; Griffiths AD; Pallier K; Blons H; Bouché O; Landi B; Hutchison JB; Laurent-Puig P
    Clin Chem; 2013 Dec; 59(12):1722-31. PubMed ID: 23938455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS genotyping by digital PCR combined with melting curve analysis.
    Tanaka J; Nakagawa T; Shiratori A; Shimazaki Y; Uematsu C; Kamahori M; Yokoi T; Harada K; Kohara Y
    Sci Rep; 2019 Feb; 9(1):2626. PubMed ID: 30796246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance.
    Okada T; Mizukami Y; Ono Y; Sato H; Hayashi A; Kawabata H; Koizumi K; Masuda S; Teshima S; Takahashi K; Katanuma A; Omori Y; Iwano H; Yamada M; Yokochi T; Asahara S; Kawakubo K; Kuwatani M; Sakamoto N; Enomoto K; Goto T; Sasajima J; Fujiya M; Ueda J; Matsumoto S; Taniue K; Sugitani A; Karasaki H; Okumura T
    J Gastroenterol; 2020 Dec; 55(12):1183-1193. PubMed ID: 32939577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of digital PCR conditions for direct detection of KRAS mutations.
    Lee J; Kim JH; Kang SH; Yoo HM
    J Clin Lab Anal; 2020 Aug; 34(8):e23344. PubMed ID: 32329932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant
    Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
    Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer.
    Bernard V; Kim DU; San Lucas FA; Castillo J; Allenson K; Mulu FC; Stephens BM; Huang J; Semaan A; Guerrero PA; Kamyabi N; Zhao J; Hurd MW; Koay EJ; Taniguchi CM; Herman JM; Javle M; Wolff R; Katz M; Varadhachary G; Maitra A; Alvarez HA
    Gastroenterology; 2019 Jan; 156(1):108-118.e4. PubMed ID: 30240661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer.
    Brychta N; Krahn T; von Ahsen O
    Clin Chem; 2016 Nov; 62(11):1482-1491. PubMed ID: 27591291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-amplification at lower denaturation-temperature PCR combined with unlabled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in plasma-circulating DNA of pancreatic adenocarcinoma cases.
    Wu J; Zhou Y; Zhang CY; Song BB; Wang BL; Pan BS; Lou WH; Guo W
    Asian Pac J Cancer Prev; 2014; 15(24):10647-52. PubMed ID: 25605154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer.
    Crucitta S; Ruglioni M; Novi C; Manganiello M; Arici R; Petrini I; Pardini E; Cucchiara F; Marmorino F; Cremolini C; Fogli S; Danesi R; Del Re M
    Clin Chim Acta; 2023 Feb; 541():117239. PubMed ID: 36736684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective capture of plasma cell-free tumor DNA on magnetic beads: a sensitive and versatile tool for liquid biopsy.
    Kerachian MA; Azghandi M; Javadmanesh A; Ghaffarzadegan K; Mozaffari-Jovin S
    Cell Oncol (Dordr); 2020 Oct; 43(5):949-956. PubMed ID: 32495293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Local Recurrence of Pancreatic Cancer by KRAS Mutation Analysis Using Washes from Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
    Matsumoto K; Kato H; Nouso K; Ako S; Kinugasa H; Horiguchi S; Saragai Y; Takada S; Yabe S; Muro S; Uchida D; Tomoda T; Okada H
    Dig Dis Sci; 2020 Oct; 65(10):2907-2913. PubMed ID: 31897893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex Enrichment and Detection of Rare KRAS Mutations in Liquid Biopsy Samples using Digital Droplet Pre-Amplification.
    Pratt ED; Cowan RW; Manning SL; Qiao E; Cameron H; Schradle K; Simeone DM; Zhen DB
    Anal Chem; 2019 Jun; 91(12):7516-7523. PubMed ID: 31072097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.
    Lamy PJ; Castan F; Lozano N; Montélion C; Audran P; Bibeau F; Roques S; Montels F; Laberenne AC
    J Mol Diagn; 2015 Jul; 17(4):366-73. PubMed ID: 25952101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.
    Watanabe F; Suzuki K; Tamaki S; Abe I; Endo Y; Takayama Y; Ishikawa H; Kakizawa N; Saito M; Futsuhara K; Noda H; Konishi F; Rikiyama T
    PLoS One; 2019; 14(12):e0227366. PubMed ID: 31891652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction.
    Lee JS; Kim M; Seong MW; Kim HS; Lee YK; Kang HJ
    Clin Chem Lab Med; 2020 Mar; 58(4):527-532. PubMed ID: 31874093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex Digital PCR Assay to Detect Multiple KRAS and GNAS Mutations Associated with Pancreatic Carcinogenesis from Minimal Specimen Amounts.
    Maeda C; Ono Y; Hayashi A; Takahashi K; Taniue K; Kakisaka R; Mori M; Ishii T; Sato H; Okada T; Kawabata H; Goto T; Tamamura N; Omori Y; Takahashi K; Katanuma A; Karasaki H; Liss AS; Mizukami Y
    J Mol Diagn; 2023 Jun; 25(6):367-377. PubMed ID: 36965665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing.
    Macgregor-Das A; Yu J; Tamura K; Abe T; Suenaga M; Shindo K; Borges M; Koi C; Kohi S; Sadakari Y; Dal Molin M; Almario JA; Ford M; Chuidian M; Burkhart R; He J; Hruban RH; Eshleman JR; Klein AP; Wolfgang CL; Canto MI; Goggins M
    J Mol Diagn; 2020 Jun; 22(6):748-756. PubMed ID: 32205290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.